cb2 and gpr55 receptors as therapeutic targets for systemic immune dysregulation
Clicks: 242
ID: 158199
2016
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
30.0
/100
241 views
24 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The endocannabinoid system (ECS) is involved in many physiological processes and has been suggested to play critical roles in the immune response and the central nervous system (CNS). Therefore, ECS modulation has potential therapeutic effects on immune dysfunctional disorders, such as sepsis and CNS injury-induced immunodeficiency syndrome (CIDS). In sepsis, excessive release of pro- and anti-inflammatory mediators results in multi-organ dysfunction/failure and death. In CIDS, an acute CNS injury dysregulates a normally well-balanced interplay between the CNS and immune system, leading to increased patients’ susceptibility to infections. In this review, we will discuss potential therapeutic modulation of the immune response in sepsis and CNS injury by manipulation of the ECS representing a novel target for immunotherapy.
| Reference Key |
zhou2016frontierscb2
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Juan Zhou;Juan Zhou;Ian Burkovskiy;Ian Burkovskiy;Hyewon Yang;Hyewon Yang;Joel Sardinha;Christian Lehmann;Christian Lehmann;Christian Lehmann |
| Journal | chemical research in chinese universities |
| Year | 2016 |
| DOI |
10.3389/fphar.2016.00264
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.